Unknown

Dataset Information

0

Engineering eukaryotic protein factories.


ABSTRACT: The biopharmaceuticals market is currently outperforming the pharmaceuticals market and is now valued at US$ 48 billion with an average annual growth of 19%. Behind this success is a 100-fold increase in productivities of eukaryotic expression systems. However, the productivity per cell has remained unchanged for more than 10 years. The engineering of the ER-resident protein folding machinery is discussed together with an overview of signal transduction pathways activated by heterologous protein overexpression to increase cell specific productivities.

SUBMITTER: Schroder M 

PROVIDER: S-EPMC2151841 | biostudies-other | 2008 Feb

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC5835717 | biostudies-literature
| S-EPMC3019746 | biostudies-literature
| S-EPMC9345862 | biostudies-literature
| S-EPMC4211546 | biostudies-literature
| S-EPMC5970105 | biostudies-literature
| S-EPMC7501233 | biostudies-literature
| S-EPMC5946454 | biostudies-literature
| S-EPMC9983209 | biostudies-literature
| S-EPMC2694678 | biostudies-literature
| S-EPMC5518134 | biostudies-other